Hui Liu 4
4 · Matinas BioPharma Holdings, Inc. · Filed Dec 3, 2020
Insider Transaction Report
Form 4
Hui Liu
Chief Technology Officer
Transactions
- Award
Stock option (right to buy)
2020-12-01+350,000→ 350,000 totalExercise: $1.07Exp: 2030-12-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests as to 25% on December 1, 2021, thereafter the remaining options vest in equal monthly installments over a period of 36 months commencing on January 1, 2022.